Mrs. Judith Kay Case, MS LMLP LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: High Plains Mental Health Center, 208 E 7th, Huys, KS 67601 Phone: 785-628-2871 |
News Archive
A Lancet study performed a systematic review of HIV prevention and treatment services targeting injecting drug users (IDUs) globally based on the availability of "core interventions for IDUs: needle and syringe programmes (NSPs), opioid substitution therapy (OST) and other drug treatment, HIV testing and counselling, antiretroviral therapy (ART), and condom programmes." The authors conclude, "although the number of countries with core HIV prevention services is growing … worldwide, there are few countries in which the level of intervention coverage is sufficient to prevent HIV transmission" (Mathers et al., 3/20).
Sequella, Inc., a clinical-stage company focused on commercializing novel drugs for treatment of life-threatening infectious diseases, announced it has signed an agreement with the Ludwig-Maximilians-University (LMU) of Munich to coordinate a European Union grant for Phase 2 clinical trials of SQ109 in adult pulmonary tuberculosis (TB) in seven sites in Africa.
Using monoclonal antibodies to fight cancer is a complex, yet promising area of study. At Memorial Sloan Kettering Cancer Center, physician-scientists have focused their attention on expanding the current therapeutic antibody repertoire, and believe a newly developed platform will do just that - ultimately leading to new and innovative treatments for cancer patients with a broad range of malignancies.
In an article now being published in the leading American journal PNAS, a research team led by Barbara Cannon and Jan Nedergaard at the Wenner-Gren Institute, Stockholm University in Sweden, together with British and American scientists, have managed to show for the first time that the cells that become the so-called brown or white fat tissue already know from the very beginning what sort of fat tissue they will be.
› Verified 2 days ago